Showing results (411-420 of 433) with videos related to

Sort By:
Pageof 44
Nature Communications|February 11, 2018
Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanomaMelanie Werner-Klein, Sebastian Scheitler, Martin Hoffmann, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2019
Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer PatientsAndré Franken, Ellen Honisch, Florian Reinhardt, et al.
International Journal of Cancer|December 20, 2021
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive diseaseAnja Kathrin Wege, Eva-Maria Rom-Jurek, Paul Jank, et al.
International Journal of Cancer|February 3, 2023
Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapyDaria Klusa, Fabian Lohaus, Andre Franken, et al.
Investigational New Drugs|March 17, 2017
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II studyRavi Salgia, R Waide Weaver, Michael McCleod, et al.
Oncotarget|May 4, 2018
Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatmentFlorian Lüke, Raquel Blazquez, Rezan Fahrioglu Yamaci, et al.
British Journal of Cancer|February 24, 2023
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical valueAndré Franken, Annika Kraemer, Alicia Sicking, et al.
Blood|August 18, 2022
Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AMLMaike Roas, Binje Vick, Marc-André Kasper, et al.
Blood|July 24, 2013
Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemiaSabrina Opatz, Harald Polzer, Tobias Herold, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trialsAngela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
Pageof 44